Registered number
13867606
PHARMABHANA LTD
Filleted Accounts
31 January 2025
PHARMABHANA LTD
Registered number: 13867606
Balance Sheet
as at 31 January 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 1,798 -
Current assets
Cash at bank and in hand 3,049 5,368
Creditors: amounts falling due within one year 4 (1,415) (4,038)
Net current assets 1,634 1,330
Net assets 3,432 1,330
Capital and reserves
Called up share capital 100 100
Profit and loss account 3,332 1,230
Shareholders' funds 3,432 1,330
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
ABDULLAH BHANA
Director
Approved by the board on 26 February 2025
PHARMABHANA LTD
Notes to the Accounts
for the year ended 31 January 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 10 years
Fixtures, fittings, tools and equipment over 10 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 2 0
3 Tangible fixed assets
Plant and machinery etc
£
Cost
Additions 1,998
At 31 January 2025 1,998
Depreciation
Charge for the year 200
At 31 January 2025 200
Net book value
At 31 January 2025 1,798
4 Creditors: amounts falling due within one year 2025 2024
£ £
Taxation and social security costs 544 2,916
Other creditors 871 1,122
1,415 4,038
5 Controlling party
The company is under the full control of the 2 directors by virtue of them owning the fully issued share capital.
6 Other information
PHARMABHANA LTD is a private company limited by shares and incorporated in England. Its registered office is:
79 HUMPHREY ROAD
MANCHESTER
M16 9DE
PHARMABHANA LTD 13867606 false 2024-02-01 2025-01-31 2025-01-31 VT Final Accounts July 2024 ABDULLAH BHANA No description of principal activity 13867606 2023-02-01 2024-01-31 13867606 core:WithinOneYear 2024-01-31 13867606 core:ShareCapital 2024-01-31 13867606 core:RetainedEarningsAccumulatedLosses 2024-01-31 13867606 2024-02-01 2025-01-31 13867606 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 13867606 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 13867606 bus:Director40 2024-02-01 2025-01-31 13867606 1 2024-02-01 2025-01-31 13867606 2 2024-02-01 2025-01-31 13867606 core:PlantMachinery 2024-02-01 2025-01-31 13867606 countries:England 2024-02-01 2025-01-31 13867606 bus:FRS102 2024-02-01 2025-01-31 13867606 bus:FilletedAccounts 2024-02-01 2025-01-31 13867606 2025-01-31 13867606 core:WithinOneYear 2025-01-31 13867606 core:ShareCapital 2025-01-31 13867606 core:RetainedEarningsAccumulatedLosses 2025-01-31 13867606 core:PlantMachinery 2025-01-31 13867606 2024-01-31 iso4217:GBP xbrli:pure